AR030862A1 - Formulaciones medicinales en aerosol - Google Patents
Formulaciones medicinales en aerosolInfo
- Publication number
- AR030862A1 AR030862A1 ARP010104722A ARP010104722A AR030862A1 AR 030862 A1 AR030862 A1 AR 030862A1 AR P010104722 A ARP010104722 A AR P010104722A AR P010104722 A ARP010104722 A AR P010104722A AR 030862 A1 AR030862 A1 AR 030862A1
- Authority
- AR
- Argentina
- Prior art keywords
- aerosol
- bulking
- medical formulations
- less
- propiliodone
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000000443 aerosol Substances 0.000 title 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 239000004067 bulking agent Substances 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 239000008249 pharmaceutical aerosol Substances 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 239000003380 propellant Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0024711.4A GB0024711D0 (en) | 2000-10-09 | 2000-10-09 | Medicinal aerosol formulations |
| GBGB0122512.7A GB0122512D0 (en) | 2000-10-09 | 2001-09-18 | Medical aerosol formations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR030862A1 true AR030862A1 (es) | 2003-09-03 |
Family
ID=26245133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010104722A AR030862A1 (es) | 2000-10-09 | 2001-10-09 | Formulaciones medicinales en aerosol |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1324749B1 (fr) |
| JP (1) | JP5021149B2 (fr) |
| CN (1) | CN1635870A (fr) |
| AR (1) | AR030862A1 (fr) |
| AT (1) | ATE320242T1 (fr) |
| AU (2) | AU2002211311B2 (fr) |
| CA (1) | CA2425035A1 (fr) |
| CZ (1) | CZ2003983A3 (fr) |
| DE (1) | DE60118021T2 (fr) |
| ES (1) | ES2260299T3 (fr) |
| HU (1) | HUP0302311A3 (fr) |
| IL (1) | IL155088A0 (fr) |
| MX (1) | MXPA03002991A (fr) |
| NO (1) | NO20031597L (fr) |
| NZ (1) | NZ525054A (fr) |
| PL (1) | PL199420B1 (fr) |
| WO (1) | WO2002030394A2 (fr) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1920763T3 (da) | 2000-11-30 | 2014-07-07 | Vectura Ltd | Farrmaceutiske præparater til inhalation |
| US8580306B2 (en) | 2000-11-30 | 2013-11-12 | Vectura Limited | Particles for use in a pharmaceutical composition |
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| GB0207906D0 (en) * | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and mometasone aerosol formulations |
| ATE353231T1 (de) * | 2002-08-23 | 2007-02-15 | Schering Corp | Pharmazeutische zusammensetzungen |
| US7109247B2 (en) | 2003-05-30 | 2006-09-19 | 3M Innovative Properties Company | Stabilized particle dispersions containing nanoparticles |
| US7459146B2 (en) * | 2003-05-30 | 2008-12-02 | 3M Innovative Properties Company | Stabilized aerosol dispersions |
| CA2528479A1 (fr) | 2003-06-13 | 2004-12-23 | Altana Pharma Ag | Combinaison de formoterol et de ciclesonide |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| US8371292B2 (en) | 2003-09-16 | 2013-02-12 | Nycomed Gmbh | Use of ciclesonide for the treatment of respiratory diseases |
| GB0323684D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| EP1811981B1 (fr) * | 2004-10-12 | 2008-08-13 | Merck Generics (UK) Limited | Procede pour la preparation d'une suspension a pulveriser, caracterise en ce que les particules sont formees a l'interieur du flacon d'aerosol |
| EP1949891A1 (fr) * | 2004-10-12 | 2008-07-30 | Generics (UK) Limited | Procédé pour la préparation de formules à suspension pour aérosol, caractérisé en ce que les particles soient formées par précipitation à l'intérieur d'un récipient |
| US9365905B2 (en) | 2005-02-10 | 2016-06-14 | Dmv-Fonterra Excipients Technology Gmbh | Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
| CN100335038C (zh) * | 2005-07-25 | 2007-09-05 | 江桥 | 含有生物活性物质和中药成分包封的无机盐纳米粒子的制备方法 |
| CN100435784C (zh) * | 2005-07-25 | 2008-11-26 | 管晓虹 | 含有和包封中药成分的无机盐纳米粒子的制备方法 |
| DE102006040535A1 (de) * | 2006-08-30 | 2008-03-13 | Beiersdorf Ag | Aerosolzubereitung umfassend Peloide |
| CN101380309B (zh) * | 2007-09-03 | 2012-05-09 | 李浩莹 | 一种定量吸入气雾剂及其制备方法 |
| GB0918150D0 (en) * | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved formulations |
| GB0918149D0 (en) | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
| AR079451A1 (es) | 2009-12-18 | 2012-01-25 | Nycomed Gmbh | Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina |
| EP2721036B1 (fr) | 2011-06-15 | 2015-07-22 | Takeda GmbH | Nouveaux composés de 3,4,4a,10b-tétrahydro-1h-thiopyrano[4,3-c]isoquinoline |
| US20140112945A1 (en) | 2011-06-17 | 2014-04-24 | Takeda Gmbh | Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives |
| WO2018069210A1 (fr) | 2016-10-10 | 2018-04-19 | Takeda Gmbh | Tétrahydrofuro [3,4-c] isoquinolines en tant qu'inhibiteurs de pde4 |
| CN109464429B (zh) * | 2018-12-13 | 2021-04-27 | 上海方予健康医药科技有限公司 | 一种吸入压力定量气雾剂药物组合物及其制备方法 |
| CN110755414A (zh) * | 2019-11-12 | 2020-02-07 | 南京华盖制药有限公司 | 一种酒石酸阿福特罗气雾剂及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9001635D0 (en) * | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
| US5747001A (en) * | 1995-02-24 | 1998-05-05 | Nanosystems, L.L.C. | Aerosols containing beclomethazone nanoparticle dispersions |
| CA2213638C (fr) * | 1995-02-24 | 2004-05-04 | Nanosystems L.L.C. | Aerosols contenant des dispersions de nanoparticules |
-
2001
- 2001-10-01 PL PL361135A patent/PL199420B1/pl not_active IP Right Cessation
- 2001-10-01 MX MXPA03002991A patent/MXPA03002991A/es unknown
- 2001-10-01 IL IL15508801A patent/IL155088A0/xx unknown
- 2001-10-01 DE DE60118021T patent/DE60118021T2/de not_active Expired - Lifetime
- 2001-10-01 EP EP01979338A patent/EP1324749B1/fr not_active Expired - Lifetime
- 2001-10-01 CA CA002425035A patent/CA2425035A1/fr not_active Abandoned
- 2001-10-01 WO PCT/US2001/030575 patent/WO2002030394A2/fr not_active Ceased
- 2001-10-01 ES ES01979338T patent/ES2260299T3/es not_active Expired - Lifetime
- 2001-10-01 JP JP2002533837A patent/JP5021149B2/ja not_active Expired - Fee Related
- 2001-10-01 HU HU0302311A patent/HUP0302311A3/hu unknown
- 2001-10-01 CZ CZ2003983A patent/CZ2003983A3/cs unknown
- 2001-10-01 AT AT01979338T patent/ATE320242T1/de not_active IP Right Cessation
- 2001-10-01 AU AU2002211311A patent/AU2002211311B2/en not_active Ceased
- 2001-10-01 CN CNA018169171A patent/CN1635870A/zh active Pending
- 2001-10-01 AU AU1131102A patent/AU1131102A/xx active Pending
- 2001-10-01 NZ NZ525054A patent/NZ525054A/en unknown
- 2001-10-09 AR ARP010104722A patent/AR030862A1/es not_active Application Discontinuation
-
2003
- 2003-04-08 NO NO20031597A patent/NO20031597L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002030394A3 (fr) | 2003-01-30 |
| NO20031597D0 (no) | 2003-04-08 |
| DE60118021D1 (de) | 2006-05-11 |
| ATE320242T1 (de) | 2006-04-15 |
| PL361135A1 (en) | 2004-09-20 |
| CZ2003983A3 (cs) | 2003-09-17 |
| AU2002211311B2 (en) | 2006-08-31 |
| MXPA03002991A (es) | 2004-05-05 |
| JP2004510808A (ja) | 2004-04-08 |
| NO20031597L (no) | 2003-05-30 |
| WO2002030394A2 (fr) | 2002-04-18 |
| JP5021149B2 (ja) | 2012-09-05 |
| CN1635870A (zh) | 2005-07-06 |
| AU1131102A (en) | 2002-04-22 |
| HUP0302311A2 (hu) | 2003-10-28 |
| EP1324749A2 (fr) | 2003-07-09 |
| IL155088A0 (en) | 2003-10-31 |
| PL199420B1 (pl) | 2008-09-30 |
| NZ525054A (en) | 2004-11-26 |
| DE60118021T2 (de) | 2006-10-26 |
| ES2260299T3 (es) | 2006-11-01 |
| CA2425035A1 (fr) | 2002-04-18 |
| EP1324749B1 (fr) | 2006-03-15 |
| HUP0302311A3 (en) | 2006-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR030862A1 (es) | Formulaciones medicinales en aerosol | |
| WO2004060351A3 (fr) | Formulation pharmaceutique ayant un agent actif insoluble | |
| ES2193726T3 (es) | Formulaciones de aerosol medicinales. | |
| BR0207005A (pt) | Sistema de distribuição granular, processo para prepará-lo, uso do mesmo, produto ou composição flavorizado(a), e, produto ou composição perfumado(a) | |
| AR018252A1 (es) | Forma de dosificacion farmaceutica en particulas solidas adecuada para suministro oral. | |
| IT1296914B1 (it) | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera | |
| TR200302105T4 (tr) | Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları. | |
| DE60334924D1 (de) | Anoteilchengrösse | |
| AR024343A1 (es) | Composiciones para champu formadoras de mousse. | |
| DE69915733D1 (de) | Kosmetische oder pharmazeutische Zusammensetzung in Form eines Feststoffs, welche verformt werden kann | |
| ES2136883T3 (es) | Nueva formulacion mejorada de aminoglucosido para administracion en forma de aerosol. | |
| SE0002643D0 (sv) | Microparticle inhalation formulations | |
| ATE386506T1 (de) | Verabreichung unlöslicher arzneistoffe | |
| AR043272A1 (es) | Una microparticula recubierta con una sustancia lipofilica que contiene una droga proteica o antigeno y formulaciones que la comprenden | |
| DE60121570D1 (de) | Oral anzuwendende schnell zerfallende feste darreichungsformen | |
| DK1435909T3 (da) | Stabil sammensætning indeholdende partikler i en frossen vandig matrix | |
| WO2005032511A3 (fr) | Agents therapeutiques nanoparticulaires biologiquement actifs | |
| ATE332126T1 (de) | Geschmacksmaskierte pharmazeutische zusammensetzungen | |
| DE60107862D1 (de) | Inhalationspartikel bestehend aus mindestens zwei wirkstoffen | |
| CO4940408A1 (es) | Composicion de aerosol farmaceutico | |
| CO5611097A2 (es) | Tableta farmaceutica | |
| ATE420624T1 (de) | Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen | |
| DE50310435D1 (de) | Filmförmige, zerfallsfähige zubereitungen zur wirkstoff-freisetzung und verfahren zu deren herstellung | |
| JO2325B1 (en) | A pharmaceutical composition with a flavoring taste and a process to prepare it | |
| BRPI0014878B8 (pt) | composição farmacêutica contendo ciclosonida para aplicação à mucosa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |